Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Vasc Endovasc Surg ; 27(5): 553-8, 2004 May.
Article in English | MEDLINE | ID: mdl-15079783

ABSTRACT

OBJECTIVE: This study tests whether sialic acid is a mediator of the lung injury following lower extremity ischemia/reperfusion (I/R). Design. Prospective randomised study. MATERIALS AND METHODS: Thirty-one Sprague-Dawley rats were randomised into four groups: group 1, aorta was exposed but not clamped; group 2, aorta clamped for 3 h, followed by 1 h of reperfusion; group 3, 50 mg/kg pentoxifylline administrated before the aorta was clamped; and group 4, 1 mg/kg dexametasone administrated before the aorta was clamped. Serial arterial blood samples for blood gas, tumor necrosis factor-alpha (TNF-alpha), and total SA (TSA) assay were obtained. The lungs were removed and histologically examined for evidence of injury. RESULTS: Groups 2, 3, and 4 had significantly higher peak serum TSA concentrations compared with groups 1 (group 1 vs. 2, p=0.001; group 1 vs. 3, p=0.002; group 1 vs. 4, p=0.001). Group 3 had lower peak serum TSA concentration. Groups 2 and 4 had significantly higher peak serum TNF-alpha concentrations (p=0.0001) compared with groups 1 and 3. Group 3 had lower peak serum TNF-alpha concentration. Lower TSA and TNF-alpha levels are associated with lesser degrees of lung injury. CONCLUSIONS: TSA and TNF appear during events that lead to lung injury following lower extremity I/R.


Subject(s)
Lung/pathology , N-Acetylneuraminic Acid/physiology , Reperfusion Injury/physiopathology , Analysis of Variance , Animals , Biomarkers , Enzyme-Linked Immunosorbent Assay , Lung/blood supply , Lung/metabolism , Male , Prospective Studies , Rats , Rats, Sprague-Dawley , Reperfusion Injury/metabolism , Statistics, Nonparametric , Tumor Necrosis Factor-alpha/metabolism
3.
J Diabetes Complications ; 13(5-6): 251-3, 1999.
Article in English | MEDLINE | ID: mdl-10764998

ABSTRACT

In this study, the serum total, free and ester carnitine levels in 24 type II diabetes mellitus (DM) patients with complications and 15 type II DM patients with no complications were investigated. The patients were investigated in four groups; the control group included the patients with no complications (group 1), the groups including the patients with retinopathy (group 2), hyperlipidemia (group 3), and neuropathy (group 4). In addition, patients were grouped into two. The first group included 10 patients who took insulin by injection (group 5), and the second group included 29 patients using antidiabetic drugs orally (OAD) (group 6). Free and ester carnitine levels were determined by using Boehringer Manheim UV-enzymatic L-carnitine kit. Statistical analysis results showed that both the plasma total and free carnitine levels of groups 2, 3, and 4 were found to be low when compared to the levels of group 1 (p < 0.05). It was observed that the plasma total and free carnitine levels of group 5 were lower when compared to group 6. No significant difference was observed between the plasma ester carnitine levels of all the groups investigated. As a result of this study, it has been thought that carnitine plays an important role in diabetes mellitus complications.


Subject(s)
Carnitine/blood , Carnitine/deficiency , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Diabetic Neuropathies/blood , Diabetic Retinopathy/blood , Hyperlipidemias/blood , Cholesterol/blood , Diabetes Mellitus, Type 2/drug therapy , Female , Humans , Hyperlipidemias/complications , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Lipoproteins, HDL/blood , Lipoproteins, LDL/blood , Lipoproteins, VLDL/blood , Male , Middle Aged
4.
Clin Nephrol ; 45(5): 310-4, 1996 May.
Article in English | MEDLINE | ID: mdl-8738662

ABSTRACT

From March 1992 to July 1992, 30 uremic patients (15 dialysed, 15 non-dialysed) and 15 non-uremic patients who had dyspeptic complaints were compared in terms of gastric and duodenal diseases. Gastritis and duodenitis graded as I, II and III were not found different in three groups (p > 0.05). Although the incidence of peptic ulcer disease is very high in both groups of uremic patients in comparison with the controls, there was no significant difference between two uremic groups (p > 0.05). Also the prevalence of gastritis determined histologically was not different in dialysed and non-dialysed uremic patients (p > 0.05). The incidence of the histologically proven gastritis was found higher in uremic patients than in non-uremic patients (p < 0.05). But, there were no significant differences among the three groups with regard to the rate of histologically proved duodenitis (p > 0.05). Gastrin levels, urea positivity, the incidence of gastritis and duodenitis and peptic ulcers did not differ in both uremic groups. However, these values were found significantly high in the uremic patients when compared to non-uremics. These findings showed serum gastrin levels, H.-pylori-infection, gastritis and duodenal disease in the uremic patients to be higher than those of the control group. Moreover, no effect of hemodialysis treatment on these results was observed.


Subject(s)
Gastric Mucosa/pathology , Gastrointestinal Diseases/etiology , Intestinal Mucosa/pathology , Renal Dialysis/adverse effects , Uremia/therapy , Adult , Aged , Aged, 80 and over , Endoscopy, Digestive System , Female , Gastrins/blood , Gastrointestinal Diseases/blood , Gastrointestinal Diseases/pathology , Humans , Incidence , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/etiology , Kidney Failure, Chronic/therapy , Male , Middle Aged , Prevalence , Retrospective Studies , Uremia/blood , Uremia/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...